Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain

Summary

The purpose of this study is to evaluate the safety and tolerability of a single intravenous dose of PG110, a monoclonal antibody that inhibits the effects of the naturally occurring substance, nerve growth factor (NGF).

Timeline

Start

2009-08

Primary completion

2011-01

Completion

2011-01

Drugs

Indications